--- title: "Weekly Recap | Cameco +4.88%, most brokers rate it buy" type: "News" locale: "en" url: "https://longbridge.com/en/news/296667314.md" description: "Cameco gained 4.88% this week, closing at $102.51 against a 1.43% decline in the S&P 500, outperforming the benchmark by roughly 6.31 percentage points. The week played out as a sharp rebound: shares opened at $97.87 on Monday and edged higher, only to tumble to an intraweek low of $93.91 on Tuesday. From there, the stock steadily recovered ground across the next three sessions. Friday saw a gap-up open and a rally to $102.82, near the session high, with volume surging to 3." datetime: "2026-08-22T04:39:26.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296667314.md) - [en](https://longbridge.com/en/news/296667314.md) - [zh-HK](https://longbridge.com/zh-HK/news/296667314.md) generator: "portal-rs" --- # Weekly Recap | Cameco +4.88%, most brokers rate it buy ## The Week Cameco gained 4.88% this week, closing at $102.51 against a 1.43% decline in the S&P 500, outperforming the benchmark by roughly 6.31 percentage points. The week played out as a sharp rebound: shares opened at $97.87 on Monday and edged higher, only to tumble to an intraweek low of $93.91 on Tuesday. From there, the stock steadily recovered ground across the next three sessions. Friday saw a gap-up open and a rally to $102.82, near the session high, with volume surging to 3.94 million shares—the heaviest day of the week. ## Key Events Nuclear energy names drew renewed attention this week. On Monday, a flurry of commentary highlighted the sector’s role as power demand stays elevated, with Cameco flagged as a stock some investors may be overlooking. Old West Investment Management disclosed a new position in Cameco the same day. While a single filing, it landed alongside a broader narrative: Google, Amazon and Meta all raised their capex guidance again, reinforcing the long-term demand case for baseload nuclear power regardless of which AI infrastructure buildout wins out. On Wednesday, a large volume of put options changed hands, suggesting some traders opted to hedge near-term swings. Friday brought a 7.24% pop, capping the strongest session of the week for the stock. ## Analyst Ratings As of 21 August 2026, 22 brokers cover Cameco: 11 rate it buy, 9 overweight and 2 hold. No underweight or sell ratings are in place. The consensus rating is ‘buy’, with a consensus target of $129.70, implying roughly 26.5% potential upside from the current price. The target range runs from $85.06 to $176.30, pointing to a wide dispersion of views among analysts. Cameco ranks first out of 14 names in the coal and consumable fuels industry. ## The Week Ahead On the macro side, Tuesday 25 August brings a packed slate of US data: FHFA house prices, the Case Shiller 20-city index, consumer confidence, new home sales and the Richmond Fed composite index. The readings will offer the latest pulse on economic resilience and could shift sentiment across rate-sensitive pockets of the market. For Cameco, the Q3 2026 earnings report is scheduled for 30 October before the open, with consensus estimates pencilling in EPS of $0.27 on revenue of $527 million. The quarter is not yet in a quiet period, but the trajectory of spot uranium prices and contract delivery cadence will be priced in well before the print. ## In Short Cameco bucked a down week for the broader market, signalling a degree of conviction behind the nuclear thesis. The analyst community remains broadly favourable, with a consensus target offering more than a quarter of upside from current levels. That said, a trailing P/E above 175x and a price-to-book near 8.9x show the market is already pricing in a lot of the long-term story. The latest session’s flow data showed large-lot money as a net seller, a contrast to the stock’s surge. The key questions ahead are whether macro data rattles positioning and whether spot uranium prices can sustain the bid—both will shape whether this week’s rally extends. *This article is generated by LongbridgeAI from market data, for information only and not investment advice.* ### Related Stocks - [CCJ.US](https://longbridge.com/en/quote/CCJ.US.md) ## Related News & Research - [Traders Purchase Large Volume of Put Options on Cameco (NYSE:CCJ)](https://longbridge.com/en/news/296280197.md) - [CCO: Lower earnings offset by higher uranium prices and robust demand outlook](https://longbridge.com/en/news/294501700.md) - [2 nuclear stocks to buy and what each one needs to go right](https://longbridge.com/en/news/296378735.md) - [ROI-The little reactors that could? How SMRs became nuclear's best bet: Maguire](https://longbridge.com/en/news/296308425.md) - [What is the best nuclear reactor stock you should put $1,000 into in 2026?](https://longbridge.com/en/news/296133427.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**